Medical Decision Making

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register today!

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Man-Son-Hing, M.
Right arrow Articles by McAlister, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Man-Son-Hing, M.
Right arrow Articles by McAlister, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Medical Decision Making, Vol. 20, No. 4, 394-402 (2000)
DOI: 10.1177/0272989X0002000403
© 2000 Society for Medical Decision Making

Other

Patient Preference-based Treatment Thresholds and Recommendations

A Comparison of Decision-analytic Modeling with the Probability-tradeoff Technique

Malcolm Man-Son-Hing, MD, MSc

Address correspondence to Dr. Man-Son-Hing: Geriatric Assessment Unit, Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, ON, Canada. K1Y 4E9; telephone: (613) 761-5110; fax: (613) 761-5334; e-mail: <mhing{at}ottawahospital.on.ca<

Andreas Laupacis, MD, MSc

Address correspondence to Dr. Man-Son-Hing: Geriatric Assessment Unit, Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, ON, Canada. K1Y 4E9; telephone: (613) 761-5110; fax: (613) 761-5334; e-mail: <mhing{at}ottawahospital.on.ca<

Annette M. O'Connor, RN, PhD

Address correspondence to Dr. Man-Son-Hing: Geriatric Assessment Unit, Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, ON, Canada. K1Y 4E9; telephone: (613) 761-5110; fax: (613) 761-5334; e-mail: <mhing{at}ottawahospital.on.ca<

Douglas Coyle, MSc

Address correspondence to Dr. Man-Son-Hing: Geriatric Assessment Unit, Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, ON, Canada. K1Y 4E9; telephone: (613) 761-5110; fax: (613) 761-5334; e-mail: <mhing{at}ottawahospital.on.ca<

Renee Berquist, BScN

Address correspondence to Dr. Man-Son-Hing: Geriatric Assessment Unit, Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, ON, Canada. K1Y 4E9; telephone: (613) 761-5110; fax: (613) 761-5334; e-mail: <mhing{at}ottawahospital.on.ca<

Finlay McAlister, MD

Address correspondence to Dr. Man-Son-Hing: Geriatric Assessment Unit, Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, ON, Canada. K1Y 4E9; telephone: (613) 761-5110; fax: (613) 761-5334; e-mail: <mhing{at}ottawahospital.on.ca<

Background. Decision analysis (DA) and the probability-tradeoff technique (PTOT) are patient preference-based methods of determining optimal therapy for individuals. Using aspirin therapy for the primary prevention of stroke and myocardial infarction (MI) in elderly persons as an example, the objective of this study was to determine whether group-level treatment thresholds and individual-level treatment recommendations derived using PTOT are identical to those of DA incorporating the patients' own values. Methods. Persons in a pilot study of the efficacy of aspirin in the prevention of stroke and MI were asked to participate. Participant values and utilities for pertinent health states (e.g., minor and major stroke, MI, major bleeding episode) were determined. Then, in three hypothetical clinical situations in which the chance of stroke or MI was varied, PTOT was used to directly determine treatment thresholds for aspirin therapy (i.e., the smallest reduction in MI or stroke risk for which participants would be willing to take aspirin). Using DA modeling, with the same probabilities of events as in the PTOT exercise and incorporating participants' own values, treatment thresholds for the three clinical situations were determined. The thresholds determined by the two approaches were compared. Finally, based on these treatment thresholds, using the best estimates of the efficacy of aspirin to prevent first-time stroke and MI, PTOT and DA treatment recommendations for individual participants were compared. Results. The 42 participants reported that a major stroke was the least desirable health state, followed by MI, minor stroke, and major bleeding. The minimum risk reduction required to take aspirin was greater for MI prevention compared with stroke prevention. For the two clinical situations in which the hypothetical efficacy of aspirin to prevent stroke was varied, treatment thresholds for the PTOT versus DA approaches differed (p < 0.04), but this difference was not significant (p = 0.19) for the MI-based clinical situation. Using the best estimate of the efficacy of aspirin to prevent first-time stroke and MI, PTOT and DA treatment recommendations whether or not to take aspirin were discordant for 38% of participants (16 of 42) (p < 0.001). Conclusions. Patient preference-based group-level treatment thresholds and individual-level treatment recommendations can differ significantly depending on whether PTOT or DA is used, apparently because the two emphasize different aspects of the decision-making process. DA theory assumes that effective therapeutic decision making should maximize both quality and quantity of life; with PTOT, the emphasis for effective clinical decision making allows patients to be fully engaged in the process, thus hopefully leading to fully informed decisions that may result in satisfaction and compliance. Key words: decision making; decision analysis; patient preferences; treatment thresholds. (Med Decis Making 2000;20:394-403)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
StrokeHome page
T. Jeerakathil, J. A. Johnson, S. H. Simpson, and S. R. Majumdar
Short-Term Risk for Stroke Is Doubled in Persons With Newly Treated Type 2 Diabetes Compared With Persons Without Diabetes: A Population-Based Cohort Study
Stroke, June 1, 2007; 38(6): 1739 - 1743.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
M. Man-Son-Hing, B. F. Gage, A. A. Montgomery, A. Howitt, R. Thomson, P. J. Devereaux, J. Protheroe, T. Fahey, D. Armstrong, and A. Laupacis
Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making
Med Decis Making, September 1, 2005; 25(5): 548 - 559.
[Abstract] [PDF]


Home page
JAMAHome page
R. A. McNutt
Shared Medical Decision Making: Problems, Process, Progress
JAMA, November 24, 2004; 292(20): 2516 - 2518.
[Full Text] [PDF]


Home page
JAMAHome page
D. E. Singer
A 60-Year-Old Woman With Atrial Fibrillation
JAMA, October 22, 2003; 290(16): 2182 - 2189.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
B. F. Gage, S. D. Fihn, and R. H. White
Warfarin Therapy for an Octogenarian Who Has Atrial Fibrillation
Ann Intern Med, March 20, 2001; 134(6): 465 - 474.
[Abstract] [Full Text] [PDF]